Skip to main content

Table 3 Results of the outlet census and anti-malarial audit by country and survey year

From: What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

Country

Year

Screened (N)

Outlets the met screening criteria

Anti-malarial audit complete (N)

Anti-malarials audited (N)

QA ACT audited (N)

West & Central Africa

 Nigeria

2009

5456

2210

2113

20,841

1192

2011

7938

1567

1486

13,391

2119

2013

5148

1828

1714

14,358

4799

2015

13,483

3624

3473

33,532

9581

East Africa

 Kenya

2010

13,897

2625

1888

8376

2052

2011

11,383

2112

1854

9544

3669

2014

12,676

2477

2133

9899

3234

 Tanzania

2010

3120

710

624

5544

416

2011

3702

799

787

9701

2045

2014

4724

2160

2129

17,307

4905

 Uganda

2010

11,153

2590

2410

14,427

2893

2011

16,207

3285

3138

20,283

5495

2013

7932

3504

3307

19,777

7182

2015

9438

4780

4328

26,640

7380

Southern Africa

 Madagascar

2010

6769

2642

2414

5579

1790

2011

10,046

2854

2360

7234

3233

2013

10,149

2021

1756

6101

3851

2015

 13,481

1361

 1040

 3170

1501